Correction of Article Information in Published Research
Overview
An error in the Article Information segment of the investigation on early neurodevelopmental outcomes in children with congenital heart disease has been corrected. The funding support details have been amended to accurately reflect the contributions from relevant organizations.
Background
Accurate reporting of funding sources in clinical research is essential for transparency and integrity. The investigation into neurodevelopmental outcomes in children with congenital heart disease is particularly significant given the complexities associated with this population.
Data Highlights
No numerical or trial data is presented in the correction notice.
Key Findings
- The funding support for the original investigation was incorrectly stated.
- The corrected funding sources include the Cardiac Neurodevelopmental Outcome Collaborative (CNOC), the Pediatric Cardiac Critical Care Consortium (PC4), and the Children’s Heart Foundation.
- Related articles have also issued corrections regarding author names and publication dates.
- Emerging strategies for neuroprotection include monitoring cerebral perfusion and coordinated rehabilitative services.
Clinical Implications
Clinicians should ensure that they are aware of the corrected funding sources when referencing the study. Accurate information is crucial for understanding the context and support behind research findings in pediatric cardiology.
Conclusion
The correction of the funding information enhances the integrity of the research on neurodevelopmental outcomes in children with congenital heart disease. Continued attention to detail in published research is vital for maintaining trust in clinical findings.
Related Resources & Content
- American Heart Association, Circulation, 2024 -- Neurodevelopmental Outcomes for Individuals With Congenital Heart Disease: Updates in Neuroprotection, Risk-Stratification, Evaluation, and Management
- JAMA Network, JAMA Network Open, 2026 -- Early Neurodevelopmental Outcomes in Children With Congenital Heart Disease
- Drug Safety — Erratum: An Overview of Post-Marketing Research Registered in the EU PAS Register and ClinicalTrials.gov Related to Pregnancy Outcomes and Breastfeeding Impacts: Insights from the ConcePTION Initiative
- Amendment to: Eliminating Background for Reducing Bias in Computer-Assisted Cytological Diagnosis
- npj Digital Medicine — Correction Notice: Optimal Guidelines and Factors for Creating and Digitally Executing Event-Driven Diaries in Clinical Research
- Amendment to: Micro-robotic Percutaneous Targeting of Type II Endoleaks in the Angio-Suite
- Neurodevelopmental Outcomes for Individuals With Congenital Heart Disease: Updates in Neuroprotection, Risk-Stratification, Evaluation, and Management: A Scientific Statement From the American Heart Association - PubMed
- Early Neurodevelopmental Outcomes in Children With Congenital Heart Disease | Pediatrics | JAMA Network Open | JAMA Network
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
